TGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation

Dafni-Eleftheria Pefani1, Daniela Pankova1, Aswin G Abraham1

  • 1CRUK/MRC Institute for Radiation Oncology and Department of Oncology, University of Oxford, Oxford OX3 7DQ UK.

Molecular Cell
|June 14, 2016
PubMed

Insights

Transforming growth factor-beta (TGF-β) triggers the degradation of RASSF1A via the ubiquitin-proteasome pathway. This degradation is crucial for YAP1/SMAD2 interaction and TGF-β-induced gene transcription, impacting tumor suppression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Epigenetic inactivation of RASSF1A is linked to poor cancer prognosis and reduced tumor suppressor activity.
  • The protein-level regulation of RASSF1A, a key Hippo pathway scaffold, remains largely unknown.
  • Understanding RASSF1A regulation is critical for elucidating its role in cancer development.

Purpose of the Study:

  • To identify the physiological signal regulating RASSF1A protein degradation.
  • To elucidate the mechanism by which RASSF1A protein levels are controlled.
  • To investigate the functional consequences of RASSF1A degradation on cancer-related signaling pathways.

Main Methods:

  • Investigated the role of transforming growth factor-beta (TGF-β) in RASSF1A regulation.
  • Utilized ubiquitin-proteasome pathway assays to study RASSF1A degradation.
  • Examined the interaction between RASSF1A, TGF-β receptor I, and the E3 ubiquitin ligase ITCH.
  • Assessed the impact of RASSF1A degradation on Hippo pathway effectors YAP1 and SMAD2.
  • Analyzed the effects on TGF-β-induced gene transcription and cellular invasion.

Main Results:

  • TGF-β was identified as the physiological signal inducing RASSF1A degradation via the ubiquitin-proteasome pathway.
  • RASSF1A is recruited to TGF-β receptor I and targeted for degradation by the E3 ubiquitin ligase ITCH.
  • RASSF1A degradation is essential for YAP1 to associate with SMADs and for SMAD2 nuclear translocation.
  • RASSF1A regulates TGF-β-induced YAP1/SMAD2 interaction, SMAD2 cytoplasmic retention, and inefficient transcription of TGF-β target genes.
  • RASSF1A limits TGF-β-induced invasion, highlighting its tumor-suppressive function.

Conclusions:

  • TGF-β-induced RASSF1A degradation is a key regulatory mechanism controlling the Hippo pathway and TGF-β signaling.
  • RASSF1A acts as a negative regulator of TGF-β-induced YAP1/SMAD2 signaling and invasion.
  • This study provides a novel framework for understanding RASSF1A's tumor-suppressive functions through modulation of YAP1 transcriptional output.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.3K